Ignite Creation Date:
2024-05-05 @ 9:24 PM
Last Modification Date:
2024-10-26 @ 10:03 AM
Study NCT ID:
NCT00870051
Status:
COMPLETED
Last Update Posted:
2022-02-09
First Post:
2009-03-25
Brief Title:
Endurant Stent Graft Natural Selection Global Postmarket Registry
Sponsor:
Medtronic Cardiovascular
Organization:
Medtronic Cardiovascular
Study Overview
Official Title:
Endurant Stent Graft Natural Selection Global Postmarket Registry
Status:
COMPLETED
Status Verified Date:
2022-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ENGAGE
Brief Summary:
The purpose of ENGAGE is to prospectively collect global real world data on the Endurant Stent Graft System from AAA subjects
Detailed Description:
The Endurant Stent Graft Natural Selection Global Post-market Registry ENGAGE is initiated to expand the clinical knowledge base by including real world subjects applying a minimal amount of subject selection criteria This subject group may better represent the subject profile treated in actual clinical practice without selecting sub-groups of particular lowhigh risk or excluding certain diseases ENGAGE aims at following and documenting the subject selections diagnostic tools used and treatment interventions chosen by the vascular surgeon or interventional radiologist ENGAGE will not impose CIP required study procedures affecting clinical practice
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None